GlassScriptPhysician profile
Mary Hatton
NPI 1871249235
$909.58
in general payments reported to CMS, 2019-2025
12 companies · $14.76 in 2025
The $14.76 reported for 2025 was less than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $475 · 2023: $420 · 2025: $14.76.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $340 · Education: $94.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $340.49 |
| Education | $94.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $272.60 | 2022-2023 | |
| Astrazeneca Pharmaceuticals LP | $224.87 | 2022-2023 | Farxiga |
| Biohaven Pharmaceutical Holding Company LTD. | $146.65 | 2022 | |
| Astellas Pharma US INC | $94.00 | 2023 | |
| Bayer Healthcare Pharmaceuticals INC. | $41.19 | 2022 | |
| Pfizer INC. | $28.34 | 2023 | |
| Alexion Pharmaceuticals, INC. | $24.95 | 2023 | Strensiq |
| Exeltis, USA INC. | $18.59 | 2023 | Slynd |
| Idorsia Pharmaceuticals US INC | $15.22 | 2023 | Quviviq |
| Hologic Sales and Service, LLC | $14.76 | 2025 | Acessa Provu System |
| Lucid Diagnostics INC. | $14.65 | 2022 | |
| Becton, Dickinson and Company | $13.76 | 2023 | Bd Onclarity |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mary Hatton listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.